News & Updates
Filter by Specialty:
Cutting first-day dexamethasone dose not recommended for breast cancer patients on anthracycline
11 Dec 2021
In breast cancer patients treated with anthracycline-containing regimens, reducing the first-day dose of dexamethasone does not yield significant gastrointestinal benefit and is not recommended for nausea management, a recent study has found.
Cutting first-day dexamethasone dose not recommended for breast cancer patients on anthracycline
11 Dec 2021
Sildenafil efficacy, safety sustained regardless of delivery method
11 Dec 2021
byAudrey Abella
Sildenafil orally disintegrating strips (ODS) are just as effective and safe as the conventional tablet formulation for the treatment of erectile dysfunction (ED), a Thai study suggests.
Sildenafil efficacy, safety sustained regardless of delivery method
11 Dec 2021
Low-dose aspirin does not stave off dementia
10 Dec 2021
byRoshini Claire Anthony
A daily 100 mg dose of aspirin for 7 years did not reduce the risk of dementia in individuals with diabetes and no history of cardiovascular disease (CVD), according to results of the ASCEND* study presented at AHA 2021.
